Trevie Research

Trevie Research is a privately held, US-based contract research organization founded in 2019 and headquartered in San Diego, with additional offices in Cambridge, MA, and Los Angeles, CA. It operates as a service provider in the biotech sector, offering specialized clinical trial management and development advisory services exclusively for oncology and immunology, with a noted partnership in the high-profile ASCENT trial for smoldering multiple myeloma. The company targets early-stage biopharma clients, leveraging its academic and KOL networks to provide a more tailored and potentially cost-effective alternative to larger CROs.

Service-based model built on deep oncology Key Opinion Leader (KOL) and academic networks, combined with specialized clinical trial management expertise and a cost-effective operational structure.

Trevie competes in the fragmented CRO market, primarily against large full-service players (e.g., IQVIA, Parexel) and other niche, therapeutic-focused CROs. Its differentiation is its exclusive oncology/immunology focus, personalized service model, and deep academic connections, which it uses to target small biotechs underserved by larger competitors.